About this Journal Submit a Manuscript Table of Contents
Hepatitis Research and Treatment
Volume 2012 (2012), Article ID 493219, 6 pages
http://dx.doi.org/10.1155/2012/493219
Review Article

The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection

Digestive Disease Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Ave, Tehran 14114, Iran

Received 18 May 2012; Revised 13 September 2012; Accepted 1 October 2012

Academic Editor: Piero Luigi Almasio

Copyright © 2012 Sirous Tayebi and Ashraf Mohamadkhani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Shokrgozar, S. Tayebi, Z. Minucheher, and A. Mohamadkhani, “Hepatitis B virus genome asymmetry in hepatocellular carcinoma,” Middle East Journal of Digestive Diseases, vol. 4, no. 3, pp. 150–157, 2012.
  2. R. Malik, P. Kennedy, D. Suri, A. Brown, R. Goldin, J. Main, et al., “The role of liver fibrosis assessment in the management of patients with chronic hepatitis B infection: lessons learned from a single centre experience,” Hepatitis Research and Treatment, vol. 2011, Article ID 524027, 5 pages, 2011. View at Publisher · View at Google Scholar
  3. T. Andus, J. Bauer, and W. Gerok, “Effects of cytokines on the liver,” Hepatology, vol. 13, no. 2, pp. 364–375, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Gonzalez-Amaro, C. Garcia-Monzon, L. Garcia-Buey et al., “Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis,” Journal of Experimental Medicine, vol. 179, no. 3, pp. 841–848, 1994. View at Scopus
  5. M. Koulentaki, G. Notas, E. Petinaki et al., “Nitric oxide and pro-inflammatory cytokines in acute hepatitis B,” European Journal of Internal Medicine, vol. 15, no. 1, pp. 35–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Vingerhoets, P. Michielsen, G. Vanham et al., “HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B,” Journal of Hepatology, vol. 28, no. 1, pp. 8–16, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Puro and R. J. Schneider, “Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA,” Journal of Virology, vol. 81, no. 14, pp. 7351–7362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Navas, I. Suarez, A. Carreno, D. Uribe, W. A. Rios, F. Cortes-Mancera, et al., “Hepatitis B and hepatitis C infection biomarkers and TP53 mutations in hepatocellular carcinomas from colombia,” Hepatitis Research and Treatment, vol. 2011, Article ID 582945, 10 pages, 2011. View at Publisher · View at Google Scholar
  9. R. F. Schwabe and D. A. Brenner, “Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 4, pp. G583–G589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mohamadkhani, K. Sayemiri, R. Ghanbari, E. Elahi, H. Poustchi, and G. Montazeri, “The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection,” Virology Journal, vol. 7, p. 228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Biermer, R. Puro, and R. J. Schneider, “Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-κB,” Journal of Virology, vol. 77, no. 7, pp. 4033–4042, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. C. Kao, J. F. Wu, Y. H. Ni et al., “Tumour necrosis factor-α promoter region polymorphisms affect the course of spontaneous HBsAg clearance,” Liver International, vol. 30, no. 10, pp. 1448–1453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Q. Chen, Y. Zeng, J. Zhou et al., “Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population,” Journal of Medical Virology, vol. 82, no. 3, pp. 371–378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Jeng, H. R. Tsai, L. Y. Chuang et al., “Independent and additive interactive effects among tumor necrosis factor-α polymorphisms, substance use habits, and chronic hepatitis b and hepatitis C virus infection on risk for hepatocellular carcinoma,” Medicine, vol. 88, no. 6, pp. 349–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Y. Xie, W. L. Wang, M. Y. Yao, S. F. Yu, X. N. Feng, J. Jin, et al., “Polymorphisms in cytokine genes and their association with acute rejection and recurrence of hepatitis B in Chinese liver transplant recipients,” Archives of Medical Research, vol. 39, no. 4, pp. 420–428, 2008.
  16. B. Basturk, Z. Karasu, M. Kilic, S. Ulukaya, S. Boyacioglu, and B. Oral, “Association of TNF-α -308 polymorphism with the outcome of hepatitis B virus infection in Turkey,” Infection, Genetics and Evolution, vol. 8, no. 1, pp. 20–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Tao, YX, and Q. Guo, “Study of the genetic polymorphisms of TNF-α promoter and the infection of HBV,” Journal of Kunming Medical University, vol. 29, pp. 45–50, 2008.
  18. P. Kummee, P. Tangkijvanich, Y. Poovorawan, and N. Hirankarn, “Association of HLA-DRB1*13 and TNF-α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population,” Journal of Viral Hepatitis, vol. 14, no. 12, pp. 841–848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. X. Xing, M. J. Zou, Q. T. Xing, H. C. Wang, and Y. S. Wang, “Relationship between proinflammatory cytokine gene polymorphisms and diseases of HBV infection,” Journal of Shandong University, vol. 45, pp. 1229–1233, 2007.
  20. P. V. Suneetha, S. K. Sarin, A. Goyal, G. T. Kumar, D. K. Shukla, and S. Hissar, “Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease,” Journal of Hepatology, vol. 44, no. 5, pp. 856–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. H. Somi, L. Najafi, B. Noori N et al., “Tumor necrosis factor-alpha gene promoter polymorphism in Iranian patients with chronic hepatitis B,” Indian Journal of Gastroenterology, vol. 25, no. 1, pp. 14–15, 2006. View at Scopus
  22. C. Li, C. Zhi-Xin, Z. Li-Juan, P. Chen, and W. Xiao-Zhong, “The association between cytokine gene polymorphisms and the outcomes of chronic HBV infection,” Hepatology Research, vol. 36, no. 3, pp. 158–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Y. Cheong, S. W. Cho, I. L. Hwang et al., “Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-α gene promoter polymorphisms,” Journal of Gastroenterology and Hepatology, vol. 21, no. 7, pp. 1163–1169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Du, X. H. Guo, X. L. Zhu et al., “Association of TNF-α promoter polymorphisms with the outcomes of hepatitis B virus infection in Chinese Han population,” Journal of Viral Hepatitis, vol. 13, no. 9, pp. 618–624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. A. Zhang, WJ, Y. Li, and P. X. Xiang, “Association of tumor necrosis factor-α gene promoter polymorphisms with susceptibility of hepatitis B virus infection,” Chinese Journal of Microcirculation, vol. 15, pp. 76–79, 2005.
  26. G. A. Niro, R. Fontana, D. Gioffreda et al., “Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection,” Liver International, vol. 25, no. 6, pp. 1175–1181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. X. W. Xu, M. H. Lu, and D. M. Tan, “Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection,” Clinical Microbiology and Infection, vol. 11, no. 1, pp. 52–56, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Liu, X. Guo, T. Du, J. H. Li, X. L. Zhu, and J. R. Gao, “Association of TNF-α polymorphisms with the outcomes of HBV infection,” Chinese Journal of Medical Genetics, vol. 22, pp. 406–410, 2005.
  29. Y. S. Zhou, F. S. Wang, M. X. Liu, L. Jin, and W. G. Hong, “Relationship between susceptibility of hepatitis B virus and gene polymorphism of tumor necrosis factor-α,” World Chinese Journal of Digestology, vol. 13, no. 2, pp. 207–210, 2005. View at Scopus
  30. Y. Liu, X. Gou, T. Du, J. H. Li, X. L. Zhu, and J. R. Gao, “Association of TNF-α polymorphisms with the outcomes of HBV infection,” Chinese Journal of Medical Genetics, vol. 22, pp. 406–410, 2005.
  31. P. A. Zhang, Y. Li, P. X. Xiang, and J. M. Wu, “Association of TNF-α gene promoter polymorphisms with outcome of hepatitis B virus infection,” World Chinese Journal of Digestology, vol. 12, no. 9, pp. 2086–2090, 2004. View at Scopus
  32. Y. J. Kim, H. S. Lee, J. H. Yoon et al., “Association of TNF-α promoter polymorphisms with the clearance of hepatitis B virus infection,” Human Molecular Genetics, vol. 12, no. 19, pp. 2541–2546, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Miyazoe, K. Hamasaki, K. Nakata et al., “Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus,” American Journal of Gastroenterology, vol. 97, no. 8, pp. 2086–2092, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Lin, Y. Cheng, D. Tian et al., “Tumor necrosis factor alpha HLA-DRB(1) gene polymorphism and genetic susceptibility to cirrhosis,” Zhonghua nei ke za zhi, vol. 41, no. 12, pp. 818–821, 2002. View at Scopus
  35. T. Heise, L. G. Guidotti, and F. V. Chisari, “La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA,” Journal of Virology, vol. 73, no. 7, pp. 5767–5776, 1999. View at Scopus
  36. M. D. Robek, S. F. Wieland, and F. V. Chisari, “Inhibition of hepatitis B virus replication by interferon requires proteasome activity,” Journal of Virology, vol. 76, no. 7, pp. 3570–3574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Lara-Pezzi, P. L. Majano, M. Gómez-Gonzalo et al., “The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes,” Hepatology, vol. 28, no. 4 I, pp. 1013–1021, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Zheng, D. D. Xiao, X. F. Lin, S. J. Wu, M. M. Peng, X. Y. Yu, et al., “The tumour necrosis factor-alpha-238A allele increases the risk of chronic HBV infection in European populations,” Journal of Viral Hepatitis, vol. 19, no. 2, pp. e11–e17, 2012.
  39. P. Zhou, G. Q. Lv, J. Z. Wang et al., “The TNF-α-238 polymorphism and cancer risk: a meta-analysis,” PLoS ONE, vol. 6, no. 7, Article ID e22092, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Y. Li, “Tumor necrosis factor-alpha g308alpha gene polymorphism and essential hypertension: a meta-analysis involving 2244 participants,” PLoS ONE, vol. 7, no. 4, Article ID e35408, 2012.
  41. L. Liu, X. Yang, X. Chen, T. Kan, Y. Shen, Z. Chen, et al., “Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis,” Molecular Biology Reports, vol. 39, no. 3, pp. 2683–2688, 2012.
  42. Y. Wei, F. Liu, B. Li et al., “Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis,” Digestive Diseases and Sciences, vol. 56, no. 8, pp. 2227–2236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Li, C. F. Hao, W. Yao, Y. X. Yun, B. Gao, and Y. X. Wang, “A meta-analysis of susceptibility to pneumoconiosis and polymorphism of tumor necrosis factor-alpha 308 and 238 locus,” Chinese Journal of Preventive Medicine, vol. 45, no. 6, pp. 547–552, 2011.
  44. B. Zhang, T. Liu, and Z. Wang, “Association of tumor necrosis factor-alpha gene promoter polymorphisms (-308G/A, -238G/A) with recurrent spontaneous abortion: a meta-analysis,” Human Immunology, vol. 73, no. 5, pp. 574–579, 2012.
  45. Z. Yang, X. Qi, Q. Wu, A. Li, P. Xu, and D. Fan, “Lack of association between TNF-α gene promoter polymorphisms and pancreatitis: a meta-analysis,” Gene, vol. 503, no. 2, pp. 229–234, 2012.
  46. C. Xie, X. F. Liu, and M. S. Yang, “A meta-analysis on the association between three promoter variants of TNF-α and Crohn's disease,” Molecular Biology Reports, vol. 39, no. 2, pp. 1575–1583, 2012.
  47. J. He, X. Pei, W. Xu, C. Wang, X. Zhang, J. Wu, et al., “The relationship between tumor necrosis factor-alpha polymorphisms and hepatitis C virus infection: a systematic review and meta-analysis,” Renal Failure, vol. 33, no. 9, pp. 915–922, 2011.
  48. L. Y. Wu, Y. Zhou, C. Qin, and B. L. Hu, “The effect of TNF-α, FcgammaR and CD1 polymorphisms on Guillain-Barre syndrome risk: evidences from a meta-analysis,” Journal of Neuroimmunology, vol. 243, no. 1-2, pp. 18–24, 2012.
  49. Q. Wang, P. Zhan, L. X. Qiu, Q. Qian, and L. K. Yu, “TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies,” Molecular Biology Reports, vol. 39, no. 4, pp. 3393–3400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. H. Lee, S. J. Choi, J. D. Ji, and G. G. Song, “CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis,” Molecular Biology Reports, vol. 39, no. 1, pp. 319–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Baena, J. Y. Leung, A. D. Sullivan et al., “TNF-α promoter single nucleotide polymorphisms are markers of human ancestry,” Genes and Immunity, vol. 3, no. 8, pp. 482–487, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. M. H. Zheng, L. X. Qiu, Y. N. Xin, H. F. Pan, K. Q. Shi, and Y. P. Chen, “Tumor necrosis factor-α-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations,” International Journal of Infectious Diseases, vol. 14, no. 7, pp. e580–e585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. L. G. Guidotti, P. Borrow, M. V. Hobbs et al., “Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 10, pp. 4589–4594, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. L. G. Guidotti, T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari, “Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes,” Immunity, vol. 4, no. 1, pp. 25–36, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. M. R. Thursz, D. Kwiatkowski, C. E. M. Allsopp, B. M. Greenwood, H. C. Thomas, and A. V. S. Hill, “Association between an MHC class II allele and clearance of hepatitis B virus in the gambia,” The New England Journal of Medicine, vol. 332, no. 16, pp. 1065–1069, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. S. H. Ahn, K. H. Han, J. Y. Park, et al., “Association between hepatitis B virus infection and HLA-DR type in Korea,” Hepatology, vol. 31, no. 6, pp. 1371–1373, 2000. View at Scopus
  57. P. Juszczynski, E. Kalinka, J. Bienvenu et al., “Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome,” Blood, vol. 100, no. 8, pp. 3037–3040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Negoro, Y. Kinouchi, N. Hiwatashi et al., “Crohn's disease is associated with novel polymorphisms in the 5'- flanking region of the tumor necrosis factor gene,” Gastroenterology, vol. 117, no. 5, pp. 1062–1068, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Higuchi, N. Seki, S. Kamizono et al., “Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese,” Tissue Antigens, vol. 51, no. 6, pp. 605–612, 1998. View at Scopus
  60. K. M. Kroeger, K. S. Carville, and L. J. Abraham, “The -308 tumor necrosis factor-α promoter polymorphism effects transcription,” Molecular Immunology, vol. 34, no. 5, pp. 391–399, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. A. G. Wilson, J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff, “Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3195–3199, 1997.
  62. H. H. Fidder, R. Heijmans, Y. Chowers et al., “TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease,” International Journal of Immunogenetics, vol. 33, no. 2, pp. 81–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. M. C. Warlé, A. Farhan, H. J. Metselaar et al., “Are cytokine gene polymorphisms related to in vitro cytokine production profiles?” Liver Transplantation, vol. 9, no. 2, pp. 170–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. C. E. Murcray, J. P. Lewinger, D. V. Conti, D. C. Thomas, and W. J. Gauderman, “Sample size requirements to detect gene-environment interactions in genome-wide association studies,” Genetic Epidemiology, vol. 35, no. 3, pp. 201–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. H. Jung, “Sample size and power calculation for molecular biology studies,” Methods in Molecular Biology, vol. 620, pp. 203–218, 2010.
  66. Y. Yang, E. F. Remmers, C. B. Ogunwole, D. L. Kastner, P. K. Gregersen, and W. Li, “Effective sample size: quick estimation of the effect of related samples in genetic case-control association analyses,” Computational Biology and Chemistry, vol. 35, no. 1, pp. 40–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Kubota and A. Wakana, “Sample-size formula for case-cohort studies,” Epidemiology, vol. 22, no. 2, p. 279, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. L. M. Chen, J. G. Ibrahim, and H. Chu, “Sample size and power determination in joint modeling of longitudinal and survival data,” Statistics in Medicine, vol. 30, no. 18, pp. 2295–2309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. S. L. West, G. Gartlehner, A. J. Mansfield, et al., “Comparative effectiveness review methods: clinical heterogeneity,” Tech. Rep. 10-EHC070-EF, Agency for Healthcare Research and Quality (US), Rockville, Md, USA, 2010, AHRQ Methods for Effective Health Care.
  70. E. W. Steyerberg and M. J. C. Eijkemans, “Heterogeneity bias: the difference between adjusted and unadjusted effects,” Medical Decision Making, vol. 24, no. 1, pp. 102–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. K. M. Kuntz and S. J. Goldie, “Assessing the sensitivity of decision-analytic results to unobserved markers of risk: defining the effects of heterogeneity bias,” Medical Decision Making, vol. 22, no. 3, pp. 218–227, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Sato, A. Watanabe, T. Tanaka et al., “Regulation of the human tumor necrosis factor-α promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors,” Journal of Molecular and Cellular Cardiology, vol. 35, no. 10, pp. 1197–1205, 2003. View at Publisher · View at Google Scholar · View at Scopus